NYSE American - Delayed Quote USD

Armata Pharmaceuticals, Inc. (ARMP)

2.5000 -0.0300 (-1.19%)
At close: April 24 at 3:41 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
40,890.0000
40,890.0000
36,946.0000
23,822.0000
21,587.0000
Operating Income
-40,890.0000
-40,890.0000
-36,946.0000
-23,822.0000
-21,587.0000
Net Non Operating Interest Income Expense
-2,447.0000
-2,447.0000
29.0000
-59.0000
-600.0000
Other Income Expense
-25,708.0000
-25,708.0000
--
726.0000
6.0000
Pretax Income
-69,045.0000
-69,045.0000
-36,917.0000
-23,155.0000
-22,181.0000
Net Income Common Stockholders
-69,045.0000
-69,045.0000
-36,917.0000
-23,155.0000
-22,181.0000
Diluted NI Available to Com Stockholders
-69,045.0000
-69,045.0000
-36,917.0000
-23,155.0000
-22,181.0000
Basic EPS
-1.65
-1.91
-1.08
-0.96
-1.35
Diluted EPS
-1.65
-1.91
-1.08
-0.96
-1.35
Basic Average Shares
36,066.3400
36,075.5550
34,294.1240
24,104.1460
16,415.0120
Diluted Average Shares
36,066.3400
36,075.5550
34,294.1240
24,104.1460
16,415.0120
Total Operating Income as Reported
-40,890.0000
-40,890.0000
-36,946.0000
-23,822.0000
-21,587.0000
Total Expenses
40,890.0000
40,890.0000
36,946.0000
23,822.0000
21,587.0000
Net Income from Continuing & Discontinued Operation
-69,045.0000
-69,045.0000
-36,917.0000
-23,155.0000
-22,181.0000
Normalized Income
-65,182.0000
-65,182.0000
-36,917.0000
-23,881.0000
-22,181.0000
Interest Income
179.0000
179.0000
29.0000
5.0000
28.0000
Interest Expense
2,626.0000
2,626.0000
--
64.0000
628.0000
Net Interest Income
-2,447.0000
-2,447.0000
29.0000
-59.0000
-600.0000
EBIT
-66,419.0000
-66,419.0000
-36,917.0000
-23,091.0000
-21,553.0000
EBITDA
-65,447.0000
-65,447.0000
-36,025.0000
-21,922.0000
-20,439.0000
Reconciled Depreciation
972.0000
972.0000
892.0000
1,169.0000
1,114.0000
Net Income from Continuing Operation Net Minority Interest
-69,045.0000
-69,045.0000
-36,917.0000
-23,155.0000
-22,181.0000
Total Unusual Items Excluding Goodwill
-3,863.0000
-3,863.0000
--
726.0000
--
Total Unusual Items
-3,863.0000
-3,863.0000
--
726.0000
--
Normalized EBITDA
-61,584.0000
-61,584.0000
-36,025.0000
-22,648.0000
-20,439.0000
12/31/2020 - 5/20/1994

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PHGE BiomX Inc.
0.3399
-1.90%
 
LENZ LENZ Therapeutics, Inc.
15.86
-0.38%
 
CWBR CohBar, Inc.
0.8000
-11.15%
 
ANRO Alto Neuroscience, Inc.
14.20
+2.31%
 
EVLO Evelo Biosciences, Inc.
0.0442
+4.00%
 
KPRX Kiora Pharmaceuticals, Inc.
0.5058
-12.72%
 
INTS Intensity Therapeutics, Inc.
3.9900
-1.48%
 
MTEM Molecular Templates, Inc.
1.6400
+5.81%
 
LABP Landos Biopharma, Inc.
22.18
+0.36%
 
XBIOW Xenetic Biosciences, Inc.
7.46
-17.11%